📰 Use Authorization News
Page 18 - Use Authorization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Use Authorization. Real-time updates on events, politics, business and more.
July 1, 2022
/PRNewswire/ -- Under the theme "We Are Changing Medicine: CytoSorb Therapy - From the Past to the Future," CytoSorbents Corporation (NASDAQ: CTSO) is bringing...
June 30, 2022
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine •105 million 30 µg, 10 µg and 3... | June 30, 2022
June 30, 2022
An advisory body announced that it has yet to receive authorization from state regulators for the rollout of second booster shots or the fourth dose of
June 30, 2022
30.06.2022 - Pfizer Inc. (NYSE: PFE) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for patients who are at high ...
June 29, 2022
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses NEW YORK and MAINZ, GERMANY, JUNE 29, 2022
June 29, 2022
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses Pfizer Inc. (NYSE: PFE) and BioNTech
June 29, 2022
Investegate announcements from BioNTech SE, Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
June 24, 2022
Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said it has submitted an application to Health Canada for its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva...
June 23, 2022
Toronto, Ontario--(Newsfile Corp. - June 23, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test
June 19, 2022
19.06.2022 - Walgreens will begin administering Pfizer and Moderna COVID-19 vaccines to children aged 3 years and older at select locations nationwide following FDA Emergency Use Authorization (EUA) and new guidance from the Centers for Disease Control and ... Seite 1